Announcing the 6th Annual John H. Kersey Memorial Lecture in translational cancer research!
We are pleased to present Dr. Caligiuri, M.D. for the 6th annual Kersey lecture. Dr. Caligiuri will be presenting Innate Lymphoid Cells and Cancer - What's the Connection? The lecture will be hosted from 9am-10am and will be streamed virtually and available to attend in person. Join us after the lecture for a reception with brunch appetizers and light refreshments.
Keynote Speaker: Michael A. Caligiuri, M.D.
A leading researcher in immunology, lymphoma and leukemia, Dr. Caligiuri dedicates himself to developing the next generation of cancer therapies, rapidly delivering them to patients and curing their disease. His research team is currently focused on bringing natural killer cellular therapies to patients with any form of cancer.
Dr. Caligiuri strives to employ an inclusive leadership style to foster greater collaboration across City of Hope and other institutions and optimize the patient care system to ensure the highest quality and safest patient experience. More than 1,000 patients have been treated on clinical trials developed or co-developed by Dr. Caligiuri.
He was elected to the National Academy of Medicine's Class of 2018 for his breakthrough discoveries in NK leukemia and cutaneous T cell lymphoma. He is also the past president of the American Association for Cancer Research, the world's largest cancer research organization with 40,000 members in 120 countries. In addition to serving as president of the AACR, he was also recently named a fellow of that organization.
In Memory of John H. Kersey, MD
John H. Kersey, MD, was a pioneer in bone marrow transplantation and studies of childhood leukemia. He obtained his MD from the University of Minnesota where he was a lifetime faculty member. Dr. Kersey directed the university's Blood and Marrow Transplant Program from 1974-1995. As Blood and Marrow Transplant Program director, he led the team that completed the world's first successful bone marrow transplant for lymphoma in 1975. Dr. Kersey was founding director of the Masonic Cancer Center, University of Minnesota 1991-2007 after which he served as director emeritus until his death in 2013. He dedicated his career to the translation of preclinical science to the bedside and was an inspiration for physician-scientists and other researchers, at Minnesota and throughout the world. The Masonic Cancer Center aims to continue his legacy by inviting internationally recognized researchers in translational research to speak at the annual John H. Kersey Memorial Lecture.
